35714-20-6

Basic information

• Product Name: 4-(Phenylmethyl)benzenemethanol
• Synonyms: 4-(Phenylmethyl)benzenemethanol;4-Benzylbenzyl alcohol;(4-Benzylphenyl)methanol
• CAS NO: 35714-20-6
• Molecular Formula: C₁₄H₁₄O
• Molecular Weight: 198.27
• Mol File: 35714-20-6.mol
• Article Data: 15

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-(Phenylmethyl)benzenemethanol(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(Phenylmethyl)benzenemethanol(35714-20-6)
• EPA Substance Registry System: 4-(Phenylmethyl)benzenemethanol(35714-20-6)

Safety Data

• Hazardous Substances Data: 35714-20-6(Hazardous Substances Data)

Upstream product

• 59016-93-2 p-hydroxymethylphenylboronic acid 
• 100-39-0 benzyl bromide 
• 873-75-6 4-bromobenzenemethanol 
• 100-44-7 benzyl chloride 
• 18908-74-2 ethyl 4-benzylbenzoate 
• 23450-30-8 methyl 4-benzylbenzoate 
• 101-81-5 Diphenylmethane 
• 17100-68-4 2-((4-bromobenzyl)oxy)tetrahydro-2H-pyran 
• 134-84-9 4-Methylbenzophenone 
• 611-95-0 4-carboxybenzophenone 
• 67-56-1 methanol 
• 100-51-6 benzyl alcohol 
• 620-86-0 4-Benzylbenzoic acid 
• 1027413-28-0 2-(4-Benzyl-benzyloxy)-tetrahydro-pyran 

Downstream Products

• 115163-68-3 phthalic acid mono-(4-benzyl-benzyl ester) 
• 67468-65-9 4-benzylbenzaldehyde 
• 880157-40-4 N-(4-Benzylbenzyl)phthalimide 
• 1027084-12-3 2-(2-{2-[2-(4-Benzyl-benzyl)-benzyl]-benzyl}-benzyloxy)-tetrahydro-pyran 
• 1026888-82-3 2-{2-[2-(4-Benzyl-benzyl)-benzyl]-benzyloxy}-tetrahydro-pyran 
• 148320-01-8 2-(2-<2-(4-Benzylbenzyl)benzyl>benzyl)benzyl alcohol 
• 1025981-79-6 2-[2-(4-Benzyl-benzyl)-benzyloxy]-tetrahydro-pyran 
• 148320-00-7 2-<2-(4-Benzylbenzyl)benzyl>benzyl bromide 
• 148319-99-7 2-<2-(4-Benzylbenzyl)benzyl>benzyl alcohol 
• 148319-98-6 2-(4-Benzylbenzyl)benzyl bromide 
• 148319-97-5 2-(4-Benzylbenzyl)benzyl alcohol 
• 1005419-35-1 Methyl (2S)-2-[(tert-Butoxycarbonyl)amino]-3-[4-(4-benzylphenoxy)phenyl]Propanoate 

Relevant articles and documents

CARBAMATE DERIVATIVES OF LACTAM BASED N-ACYLETHANOLAMINE ACID AMIDASE (NAAA) INHIBITORS

Described herein are compounds and pharmaceutical compositions which inhibit N-acylethanolamine acid amidase (NAAA). Described herein are methods for synthesizing the compounds set forth herein and methods for formulating these compounds as pharmaceutical compositions which include these compounds. Also described herein are methods of inhibiting NAAA in order to sustain the levels of palmitoylethanolamide (PEA) and other N-acylethanolamines (NAE) that are substrates for NAAA, in conditions characterized by reduced concentrations of NAE. Also, described here are methods of treating and ameliorating pain, inflammation, inflammatory diseases, and other disorders in which modulation of fatty acid ethanolamides is clinically or therapeutically relevant or in which decreased levels of NAE are associated with the disorder.

MODULATORS OF C3A RECEPTOR AND METHODS OF USE THEREOF

Provided are compounds that are modulators of C3a receptor activity, compositions containing the compounds and methods of use of the compounds and compositions. In certain embodiments, the compounds are pyridones. In certain embodiments, provided are methods for treatment or amelioration of diseases associated with modulation of C3a receptor activity.

BIARYL SUBSTITUTED HETEROCYCLE INHIBITORS OF LTA4H FOR TREATING INFLAMMATION

The present invention relates to a chemical genus of biaryl substituted heterocycle inhibitors of LTA4H (leukotriene A4 hydrolase) useful for the treatment and prevention and prophylaxis of inflammatory diseases and disorders. The compounds have general formula Ψ: An example is